Silva Pharmaceuticals Limited reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was BDT 151.27 million compared to BDT 184.65 million a year ago. Net loss was BDT 8.56 million compared to net income of BDT 19.25 million a year ago. Basic loss per share from continuing operations was BDT 0.06 compared to basic earnings per share from continuing operations of BDT 0.14 a year ago.
For the six months, sales was BDT 302.96 million compared to BDT 382.3 million a year ago. Net loss was BDT 16.22 million compared to net income of BDT 45.01 million a year ago. Basic loss per share from continuing operations was BDT 0.12 compared to basic earnings per share from continuing operations of BDT 0.33 a year ago.